Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingfeng Yang

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Food Research International (Ottawa, Ont.)|November 27, 2024
Portable sensing of hydrogen peroxide using MOF-based nanozymesLingFeng Yang, Zuyao Fu, Jing Xie, et al.
Nanoscale|January 31, 2025
Immobilization of horseradish peroxidase on UiO-66-NH<sub>2</sub> for colorimetric and fluorometric sensing of nitriteZuyao Fu, Lingfeng Yang, Zhaoyang Ding, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 5, 2019
Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UKDominik Lautsch, Tongtong Wang, Lingfeng Yang, et al.
Brain Sciences|December 24, 2025
Advancements and Applications of EEG in Gustatory PerceptionLingfeng Yang, Chengpeng Zhang, Wei Wu, et al.
Diabetes Care|March 1, 2003
Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experienceLynn E Eberly, Jerome D Cohen, Ronald Prineas, et al.
Mikrochimica Acta|June 18, 2026
Portable device integrated with a MOF-on-MOF aggregation-induced emission nanozyme for dual-mode formaldehyde detectionLingFeng Yang, Zuyao Fu, Abubakar Shuaibu, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|March 3, 2025
Fine-Grained Visual Text PromptingLingfeng Yang, Xiang Li, Yueze Wang, et al.
Frontiers in Oncology|April 11, 2022
Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1Vamsidhar Velcheti, Xiaohan Hu, Lingfeng Yang, et al.
Future Oncology (London, England)|March 25, 2021
Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 yearsJan Sieluk, Lingfeng Yang, Amin Haiderali, et al.
International Journal of Epidemiology|August 13, 2003
Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quittersLynn E Eberly, Judith Ockene, Roger Sherwin, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Food Research International (Ottawa, Ont.)|November 27, 2024
Portable sensing of hydrogen peroxide using MOF-based nanozymesLingFeng Yang, Zuyao Fu, Jing Xie, et al.
Nanoscale|January 31, 2025
Immobilization of horseradish peroxidase on UiO-66-NH<sub>2</sub> for colorimetric and fluorometric sensing of nitriteZuyao Fu, Lingfeng Yang, Zhaoyang Ding, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 5, 2019
Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UKDominik Lautsch, Tongtong Wang, Lingfeng Yang, et al.
Brain Sciences|December 24, 2025
Advancements and Applications of EEG in Gustatory PerceptionLingfeng Yang, Chengpeng Zhang, Wei Wu, et al.
Diabetes Care|March 1, 2003
Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experienceLynn E Eberly, Jerome D Cohen, Ronald Prineas, et al.
Mikrochimica Acta|June 18, 2026
Portable device integrated with a MOF-on-MOF aggregation-induced emission nanozyme for dual-mode formaldehyde detectionLingFeng Yang, Zuyao Fu, Abubakar Shuaibu, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|March 3, 2025
Fine-Grained Visual Text PromptingLingfeng Yang, Xiang Li, Yueze Wang, et al.
Frontiers in Oncology|April 11, 2022
Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1Vamsidhar Velcheti, Xiaohan Hu, Lingfeng Yang, et al.
Future Oncology (London, England)|March 25, 2021
Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 yearsJan Sieluk, Lingfeng Yang, Amin Haiderali, et al.
International Journal of Epidemiology|August 13, 2003
Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quittersLynn E Eberly, Judith Ockene, Roger Sherwin, et al.
Pageof 7